OpenVSafe by OpenVAERS
Search V-safe

SE6-20975-55971

3 vaccinations 2 coded responses 20 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
967 / HI
Registered
2020-12-25
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-24
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-25
    Registered in v-safe
  3. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Diarrhea · Be unable to work
    Adult check-in
  4. 2020-12-25
  5. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-31
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-01-07
    Survey response — day 14, dose 1
    MedDRA: Head discomfort, Headache — Feeling: Good
    Free text: Mild, constant headache/heaviness in head
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-07
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-04-17
    Dose 3 — Pfizer-BioNTech
  21. 2022-04-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2022-04-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  23. 2022-05-01
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  24. 2022-05-29
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  25. 2023-04-17
    Survey response — 12 months, dose 3
    MedDRA: Chills, Fatigue, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  26. 2023-04-17
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  27. 2023-04-18

Vaccinations

DoseDateManufacturerCo-administered
12020-12-24Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32022-04-17Pfizer-BioNTech No

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-07

Symptoms: Mild, constant headache/heaviness in head

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDFatigue · · ✓
SDHead discomfort ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDPain · · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release